A randomized controlled single blind multicenter study to investigate the induction of aluminium contact allergy in children/adults receiving hyposensitisation therapy due to allergic disease.Children and adults will answer questionnaires and be tested epicutaneously to detect aluminium hypersensitivity and possible risk factors associated with the development of contact allergy to aluminium due to hyposensitisation therapy
- Conditions
- The development of contact allergy to aluminium during hyposensitization therapy.
- Registration Number
- EUCTR2007-003000-35-SE
- Lead Sponsor
- Department of Occupational and Environmental Dermatology, Malmö University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Informed written consent given by adult participants, children more than 15 years of age and parent/guardian.
Children and adults who will start there hyposensitisation therapy during 2007 and 2008 at 22 hospital clinics in Sweden.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Experienced anaphylaxis during skin tests.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method